Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals
Howard C. Herrmann, MD*,*,
Jiandong Lu, MD ,
Bruce R. Brodie, MD ,
Paul W. Armstrong, MD ,
Gilles Montalescot, MD, PhD||,
Amadeo Betriu, MD¶,
Franz-Joseph Neuman, MD#,
Mark B. Effron, MD**,
Elliot S. Barnathan, MD,
Eric J. Topol, MD,
Stephen G. Ellis, MD for the FINESSE Investigators
* Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
Centocor Research & Development, Inc., Malvern, Pennsylvania
LeBauer Cardiovascular Research, Greensboro, North Carolina
University of Alberta Hospital, Edmonton, Alberta, Canada
|| Hôpital Pitiè-Salpétrière, Paris, France
¶ Hospital Clinic i Provincial, Barcelona, Spain
# Herz-Zentrum bad Krozingen, Bad Krozingen, Germany
** Eli Lilly and Company, Indianapolis, Indiana
The Scripps Research Institute and Scripps Clinic, La Jolla, California
Cleveland Clinic Foundation, Cleveland, Ohio
* Reprint requests and correspondence: Dr. Howard C. Herrmann, 9038 West Gates Building, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, Pennsylvania 19104 (Email: howard.herrmann{at}uphs.upenn.edu).
Objectives: We hypothesized that patients most likely to benefit would be those at high risk with a shorter duration of acute ischemia and who required transfer for percutaneous coronary intervention (PCI).
Background: The FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) study failed to demonstrate an improvement in the 90-day composite clinical end point of early treatment with abciximab plus half-dose reteplase (combination-facilitated PCI) or abciximab alone.
Methods: We performed a retrospective analysis of 2,452 patients in this double-blind, placebo-controlled study. Patients were stratified by Thrombolysis In Myocardial Infarction (TIMI) risk score for ST-segment elevation myocardial infarction (STEMI), presentation to a spoke (no PCI available) or hub site, and symptom-to-randomization time. Outcomes included the primary composite end point of death, ventricular fibrillation after 48 h, cardiogenic shock, and congestive heart failure through day 90 as well as 1-year mortality.
Results: Mortality for all patients at 1 year was directly related to TIMI risk score (23 of 1,223 = 1.9% in patients with score <3 and 145 of 1,229 = 11.8% with score  3, p < 0.001). Patients with TIMI risk score 3 and presentation to a spoke site with a symptom-to-randomization time  4 h had significantly better 1-year survival if treated with combination-facilitated PCI (hazard ratio [HR]: 0.351, p = 0.01) as well as 90-day composite outcome (HR: 0.45, p = 0.009). A trend for improved survival was also observed in patients with TIMI score 3 and spoke site alone (HR: 0.549, p = 0.06).
Conclusions: Facilitation of PCI with a combination of abciximab and half-dose reteplase improved survival at 1 year in high-risk patients presenting to a spoke hospital with symptom-to-randomization time 4 h. Further prospective study of facilitated PCI in this subgroup of patients is warranted.
Key Words: percutaneous coronary intervention • STEMI facilitation
|
Abbreviations and Acronyms
| | HR = hazard ratio | | MI = myocardial infarction | | PCI = percutaneous coronary intervention | | STEMI = ST-segment elevation myocardial infarction | | TIMI = Thrombolysis In Myocardial Infarction |
|
Related Article
-
The Ideal Reperfusion Strategy for the ST-Segment Elevation Myocardial Infarction Patient With Expected Delay to Percutaneous Coronary Intervention: Paradise Lost or Paradise Renamed?
- Timothy D. Henry and David M. Larson
J. Am. Coll. Cardiol. Intv. 2009 2: 931-933.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
A. E. Denktas, H. V. Anderson, J. McCarthy, and R. W. Smalling
Total Ischemic Time: The Correct Focus of Attention for Optimal ST-Segment Elevation Myocardial Infarction Care
J. Am. Coll. Cardiol. Intv.,
June 1, 2011;
4(6):
599 - 604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Thiele, I. Eitel, C. Meinberg, S. Desch, A. Leuschner, D. Pfeiffer, A. Hartmann, U. Lotze, W. Strauss, G. Schuler, et al.
Randomized Comparison of Pre-Hospital-Initiated Facilitated Percutaneous Coronary Intervention Versus Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction Very Early After Symptom Onset: The LIPSIA-STEMI Trial (Leipzig Immediate Prehospital Facilitated Angioplasty in ST-Segment Myocardial Infarction)
J. Am. Coll. Cardiol. Intv.,
June 1, 2011;
4(6):
605 - 614.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. R. Brodie
Facilitated Percutaneous Coronary Intervention: Still Searching for the Right Patients
J. Am. Coll. Cardiol. Intv.,
June 1, 2011;
4(6):
615 - 617.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Silvain, J.-P. Collet, C. Nagaswami, F. Beygui, K. E. Edmondson, A. Bellemain-Appaix, G. Cayla, A. Pena, D. Brugier, O. Barthelemy, et al.
Composition of Coronary Thrombus in Acute Myocardial Infarction
J. Am. Coll. Cardiol.,
March 22, 2011;
57(12):
1359 - 1367.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Prati, S. Petronio, A. J. Van Boven, M. Tendera, L. De Luca, M. A. de Belder, A. R. Galassi, F. Imola, G. Montalescot, J. Z. Peruga, et al.
Evaluation of Infarct-Related Coronary Artery Patency and Microcirculatory Function After Facilitated Percutaneous Primary Coronary Angioplasty: The FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) Study
J. Am. Coll. Cardiol. Intv.,
December 1, 2010;
3(12):
1284 - 1291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. R. Brodie, B. J. Gersh, T. Stuckey, B. Witzenbichler, G. Guagliumi, J. Z. Peruga, D. Dudek, C. L. Grines, D. Cox, H. Parise, et al.
When Is Door-to-Balloon Time Critical?: Analysis From the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trials
J. Am. Coll. Cardiol.,
July 27, 2010;
56(5):
407 - 413.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
May 18, 2010;
55(20):
2272 - 2286.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Henry and D. M. Larson
The Ideal Reperfusion Strategy for the ST-Segment Elevation Myocardial Infarction Patient With Expected Delay to Percutaneous Coronary Intervention: Paradise Lost or Paradise Renamed?
J. Am. Coll. Cardiol. Intv.,
October 1, 2009;
2(10):
931 - 933.
[Full Text]
[PDF]
|
|
|
|
